Literature DB >> 1481798

Drug prescribing for patients with changing renal function.

T G Cantú1, E F Ellerbeck, S W Yun, S D Castine, D M Kornhauser.   

Abstract

The prevalence and course of renal dysfunction in hospitalized patients and the prescribing of renally eliminated drugs in these patients were studied. All adult inpatients at a large teaching hospital who had a serum creatinine concentration assay performed were screened for renal dysfunction (an estimated creatinine clearance of < 40 mL/min). Renally compromised patients were monitored for changes in renal function. The regimens of selected renally eliminated drugs prescribed for these patients were compared with the manufacturers' recommended dosages for patients with renal compromise. Of the 3800 patients screened, 195 (5%) had renal dysfunction; most of these patients were older than 65 years. Although improvements in renal function were noted in 49 (30%) of the 169 patients with renal dysfunction who were not receiving hemodialysis, elderly patients were less likely to show an improvement in renal function. Of the 60 patients with renal dysfunction for whom a renally eliminated drug was prescribed, 27 (45%) were receiving dosages in excess of the manufacturers' recommendations. Changes in creatinine clearance estimates are common in hospitalized patients with renal impairment. Programs designed to alert physicians to potentially excessive dosages of renally eliminated drugs need to be sensitive to these changes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1481798

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  18 in total

Review 1.  Drug dosage in the elderly: dermatological drugs.

Authors:  Anna Flammiger; Howard Maibach
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 2.  Best practice in primary care pathology: review 4.

Authors:  W S A Smellie; J Forth; S Sundar; E Kalu; C A M McNulty; E Sherriff; I D Watson; C Croucher; T M Reynolds; P J Carey
Journal:  J Clin Pathol       Date:  2006-05-19       Impact factor: 3.411

Review 3.  Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin.

Authors:  W Stuart A Smellie; Jamie J Coleman
Journal:  BMJ       Date:  2007-02-10

4.  Medication dosing and renal insufficiency in a pediatric cardiac intensive unit.

Authors:  F Assadi
Journal:  Pediatr Cardiol       Date:  2008-11       Impact factor: 1.655

5.  Downregulation of hepatic acetylation of drugs in chronic renal failure.

Authors:  Emilie Simard; Judith Naud; Josée Michaud; Francois A Leblond; Alain Bonnardeaux; Chantal Guillemette; Edith Sim; Vincent Pichette
Journal:  J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 10.121

Review 6.  Principles of drug administration in renal insufficiency.

Authors:  Y W Lam; S Banerji; C Hatfield; R L Talbert
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

7.  Potentially inappropriate prescribing of renally cleared drugs in elderly patients in community and aged care settings.

Authors:  Aarati Khanal; Gregory M Peterson; Ronald L Castelino; Matthew D Jose
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

8.  Audit of renal drug dosing: comparison of 2 methods and evaluation of pharmacists' knowledge, attitudes, and behaviour.

Authors:  Kimberley L Caouette; Colette B Raymond; Lindsay D Meyer; Nicholas Honcharik
Journal:  Can J Hosp Pharm       Date:  2012-07

Review 9.  Pharmacokinetics and pharmacodynamics of low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonists in renal failure.

Authors:  B S Smith; P J Gandhi
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

10.  Evaluation of applying drug dose adjustment by physicians in patients with renal impairment.

Authors:  Abdulrahman M Alahdal; Ahmed A Elberry
Journal:  Saudi Pharm J       Date:  2011-12-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.